Smith & Nephew plc (SNNUF)
USD 14.33
(0.0%)
USD 14.33
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.17 Billion USD | -19.91% |
| 2022 | 2.71 Billion USD | -4.78% |
| 2021 | 2.84 Billion USD | -15.06% |
| 2020 | 3.35 Billion USD | 69.77% |
| 2019 | 1.97 Billion USD | 51.81% |
| 2018 | 1.3 Billion USD | -8.57% |
| 2017 | 1.42 Billion USD | -9.02% |
| 2016 | 1.56 Billion USD | 9.07% |
| 2015 | 1.43 Billion USD | -13.93% |
| 2014 | 1.66 Billion USD | 380.12% |
| 2013 | 347 Million USD | -19.3% |
| 2012 | 430 Million USD | 2587.5% |
| 2011 | 16 Million USD | -97.51% |
| 2010 | 642 Million USD | -42.52% |
| 2009 | 1.11 Billion USD | -17.75% |
| 2008 | 1.35 Billion USD | 3672.22% |
| 2007 | 36 Million USD | 140.0% |
| 2006 | 15 Million USD | -92.89% |
| 2005 | 211 Million USD | -27.91% |
| 2004 | 292.69 Million USD | 50.38% |
| 2003 | 194.64 Million USD | -26.44% |
| 2002 | 264.6 Million USD | 7.2% |
| 2001 | 246.82 Million USD | -7.63% |
| 2000 | 267.2 Million USD | 717.7% |
| 1999 | 32.67 Million USD | 53.8% |
| 1998 | 21.24 Million USD | -11.97% |
| 1997 | 24.13 Million USD | 5.97% |
| 1996 | 22.77 Million USD | 40.38% |
| 1995 | 16.22 Million USD | -42.02% |
| 1994 | 27.98 Million USD | -31.7% |
| 1993 | 40.97 Million USD | 19.54% |
| 1992 | 34.27 Million USD | -83.97% |
| 1991 | 213.87 Million USD | -5.15% |
| 1990 | 225.49 Million USD | -7.18% |
| 1989 | 242.93 Million USD | -9.88% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3.27 Billion USD | 44.51% |
| 2024 Q2 | 3.14 Billion USD | 0.0% |
| 2023 Q4 | 2.17 Billion USD | -6.34% |
| 2023 Q1 | 2.63 Billion USD | -2.91% |
| 2023 FY | 2.17 Billion USD | -19.91% |
| 2023 Q3 | 2.31 Billion USD | -11.89% |
| 2023 Q2 | 2.63 Billion USD | -0.04% |
| 2022 FY | 2.71 Billion USD | -4.78% |
| 2022 Q4 | 2.71 Billion USD | 0.0% |
| 2022 Q3 | 2.71 Billion USD | 18.9% |
| 2022 Q2 | 2.28 Billion USD | 0.0% |
| 2022 Q1 | 2.28 Billion USD | -19.91% |
| 2021 FY | 2.84 Billion USD | -15.06% |
| 2021 Q1 | 2.91 Billion USD | -13.03% |
| 2021 Q2 | 2.91 Billion USD | 0.0% |
| 2021 Q3 | 2.84 Billion USD | -2.33% |
| 2021 Q4 | 2.84 Billion USD | 0.0% |
| 2020 Q2 | 2.47 Billion USD | 0.0% |
| 2020 Q1 | 2.47 Billion USD | 25.37% |
| 2020 Q4 | 3.35 Billion USD | 0.0% |
| 2020 FY | 3.35 Billion USD | 69.77% |
| 2020 Q3 | 3.35 Billion USD | 35.42% |
| 2019 Q4 | 1.97 Billion USD | 0.0% |
| 2019 Q3 | 1.97 Billion USD | -0.25% |
| 2019 Q2 | 1.98 Billion USD | 0.0% |
| 2019 Q1 | 1.98 Billion USD | 52.19% |
| 2019 FY | 1.97 Billion USD | 51.81% |
| 2018 Q3 | 1.3 Billion USD | -8.38% |
| 2018 Q4 | 1.3 Billion USD | 0.0% |
| 2018 Q1 | 1.42 Billion USD | -0.21% |
| 2018 FY | 1.3 Billion USD | -8.57% |
| 2018 Q2 | 1.42 Billion USD | 0.0% |
| 2017 Q3 | 1.42 Billion USD | -11.28% |
| 2017 Q1 | 1.6 Billion USD | 2.56% |
| 2017 FY | 1.42 Billion USD | -9.02% |
| 2017 Q2 | 1.6 Billion USD | 0.0% |
| 2017 Q4 | 1.42 Billion USD | 0.0% |
| 2016 FY | 1.56 Billion USD | 9.07% |
| 2016 Q2 | 1.7 Billion USD | 0.0% |
| 2016 Q4 | 1.56 Billion USD | 0.0% |
| 2016 Q3 | 1.56 Billion USD | -8.43% |
| 2016 Q1 | 1.7 Billion USD | 19.11% |
| 2015 Q2 | 1.53 Billion USD | 0.0% |
| 2015 FY | 1.43 Billion USD | -13.93% |
| 2015 Q4 | 1.43 Billion USD | 0.0% |
| 2015 Q1 | 1.53 Billion USD | -8.04% |
| 2015 Q3 | 1.43 Billion USD | -6.4% |
| 2014 Q2 | 1.98 Billion USD | 489.32% |
| 2014 FY | 1.66 Billion USD | 380.12% |
| 2014 Q4 | 1.66 Billion USD | -13.95% |
| 2014 Q3 | 1.93 Billion USD | -2.52% |
| 2014 Q1 | 337 Million USD | -2.88% |
| 2013 Q4 | 347 Million USD | 20.07% |
| 2013 FY | 347 Million USD | -19.3% |
| 2013 Q1 | 209 Million USD | -51.4% |
| 2013 Q2 | 335 Million USD | 60.29% |
| 2013 Q3 | 289 Million USD | -13.73% |
| 2012 Q2 | 15 Million USD | 0.0% |
| 2012 Q4 | 430 Million USD | 2587.5% |
| 2012 FY | 430 Million USD | 2587.5% |
| 2012 Q3 | 16 Million USD | 6.67% |
| 2012 Q1 | 15 Million USD | -6.25% |
| 2011 Q1 | 528 Million USD | -17.76% |
| 2011 Q3 | 27 Million USD | -6.9% |
| 2011 Q4 | 16 Million USD | -40.74% |
| 2011 FY | 16 Million USD | -97.51% |
| 2011 Q2 | 29 Million USD | -94.51% |
| 2010 Q2 | 1.04 Billion USD | 3.05% |
| 2010 Q1 | 1.01 Billion USD | -9.04% |
| 2010 Q4 | 642 Million USD | -39.09% |
| 2010 Q3 | 1.05 Billion USD | 0.67% |
| 2010 FY | 642 Million USD | -42.52% |
| 2009 Q4 | 1.11 Billion USD | -11.91% |
| 2009 FY | 1.11 Billion USD | -17.75% |
| 2009 Q3 | 1.26 Billion USD | -2.76% |
| 2009 Q1 | 1.2 Billion USD | -11.63% |
| 2009 Q2 | 1.3 Billion USD | 8.67% |
| 2008 Q4 | 1.35 Billion USD | -2.44% |
| 2008 FY | 1.35 Billion USD | 3672.22% |
| 2008 Q1 | 37 Million USD | 2.78% |
| 2008 Q2 | 36 Million USD | -2.7% |
| 2008 Q3 | 1.39 Billion USD | 3766.67% |
| 2007 FY | 36 Million USD | 140.0% |
| 2007 Q1 | 21 Million USD | 40.0% |
| 2007 Q2 | 42 Million USD | 100.0% |
| 2007 Q3 | 40 Million USD | -4.76% |
| 2007 Q4 | 36 Million USD | -10.0% |
| 2006 FY | 15 Million USD | -92.89% |
| 2006 Q4 | 15 Million USD | -6.25% |
| 2006 Q3 | 16 Million USD | 0.0% |
| 2006 Q2 | 16 Million USD | 0.0% |
| 2006 Q1 | 16 Million USD | -87.88% |
| 2005 FY | 211 Million USD | -27.91% |
| 2005 Q3 | 186 Million USD | -63.07% |
| 2005 Q1 | 197 Million USD | -28.79% |
| 2005 Q4 | 132 Million USD | -29.03% |
| 2005 Q2 | 503.69 Million USD | 155.68% |
| 2004 Q2 | 426.25 Million USD | 1.75% |
| 2004 FY | 292.69 Million USD | 50.38% |
| 2004 Q1 | 418.91 Million USD | 115.22% |
| 2004 Q3 | 343.62 Million USD | -19.39% |
| 2004 Q4 | 276.65 Million USD | -19.49% |
| 2003 Q2 | - USD | -100.0% |
| 2003 Q1 | 563.18 Million USD | 112.84% |
| 2003 Q3 | - USD | 0.0% |
| 2003 FY | 194.64 Million USD | -26.44% |
| 2003 Q4 | 194.64 Million USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q4 | 264.6 Million USD | 0.0% |
| 2002 FY | 264.6 Million USD | 7.2% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q4 | 246.82 Million USD | 0.0% |
| 2001 FY | 246.82 Million USD | -7.63% |
| 2000 Q2 | - USD | 0.0% |
| 2000 FY | 267.2 Million USD | 717.7% |
| 2000 Q4 | 267.2 Million USD | 0.0% |
| 1999 Q4 | 32.67 Million USD | 0.0% |
| 1999 FY | 32.67 Million USD | 53.8% |
| 1999 Q2 | - USD | 0.0% |
| 1998 FY | 21.24 Million USD | -11.97% |
| 1997 FY | 24.13 Million USD | 5.97% |
| 1996 FY | 22.77 Million USD | 40.38% |
| 1995 FY | 16.22 Million USD | -42.02% |
| 1994 FY | 27.98 Million USD | -31.7% |
| 1993 FY | 40.97 Million USD | 19.54% |
| 1992 FY | 34.27 Million USD | -83.97% |
| 1991 FY | 213.87 Million USD | -5.15% |
| 1990 FY | 225.49 Million USD | -7.18% |
| 1989 FY | 242.93 Million USD | -9.88% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 12.52 Million USD | -17234.341% |
| IR-Med Inc. | 161 Thousand USD | -1348924.18% |
| Polarean Imaging plc | 74.84 Thousand USD | -2901763.734% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -1871381.319% |
| Avitar, Inc. | 3.89 Million USD | -55641.196% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -483106.023% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | -596.573% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | -11415.097% |
| Össur hf. | 311.8 Million USD | -596.573% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | -351344.811% |
| Escalon Medical Corp. | 279.4 Thousand USD | -777243.535% |
| Aurora Spine Corporation | 1.59 Million USD | -136343.724% |
| BrainsWay Ltd. | 239 Thousand USD | -908656.874% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 16.7 Million USD | -12901.007% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | -166.752% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -997978.65% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -4972720.153% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | -368023.547% |
| Nanomix Corporation | 10.11 Million USD | -21379.872% |
| Theraclion SA | 1.95 Million EUR | -111238.947% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | -712942.984% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -1447852.62% |
| Lombard Medical, Inc. | 28.02 Million USD | -7649.969% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | -2333.378% |
| Vycor Medical, Inc. | 243.28 Thousand USD | -892643.521% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -1525891.843% |
| SANUWAVE Health, Inc. | 492 Thousand USD | -441348.97% |
| VMS Rehab Systems, Inc. | 106.45 USD | -2040327687.694% |
| Guided Therapeutics, Inc. | 511 Thousand USD | -424935.016% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | -407945.625% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | -270040.414% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | -673571.047% |
| Urologix, Inc. | 4.58 Million USD | -47259.985% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | -504723.859% |
| Nexeon MedSystems Inc. | 2.78 Million USD | -77849.479% |
| SS Innovations International, Inc. | 1.91 Million USD | -113587.843% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| NIOX Group Plc | 500 Thousand USD | -434285.786% |
| Fuse Medical, Inc. | 200 Thousand USD | -1085864.465% |
| Broncus Holding Corporation | 1.22 Million USD | -177345.174% |
| Brain Scientific Inc. | 7378.00 USD | -29437809.054% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -1341723.339% |
| Health Logic Interactive Inc. | - USD | -Infinity% |